TABLE 5.
Abnormal results of cardioreflex tests in different subgroups of COVID-19 patients with associated co-morbidities.
|
N (%) |
||||||||
| CADG (n = 41) | p-value | CADG-DM (n = 7) | p-value | CADG-HTA (n = 18) | p-value | CADG-Syn (n = 16) | p-value | |
| CART | ||||||||
| Sympathetic function tests | ||||||||
| Blood pressure response to standing (OH) | 19 (46.30) | 0.001 | 4 (57.10) | 0.001 | 10 (52.90) | 0.001 | 5 (31.20) | 0.001 |
| Hand grip test (HG) | 39 (94.40) | 0.001 | 7 (100.00) | 0.001 | 18 (100.00) | 0.001 | 15 (93.70) | 0.001 |
| Parasympathetic function tests | ||||||||
| Heart rate response to Valsalva maneuver | 12 (28.90) | 0.001 | 3 (40.00) | 0.001 | 5 (27.70) | 0.001 | 6 (38.50) | 0.001 |
| Heart rate response to deep breathing | 17 (41.70) | 0.001 | 3 (40.00) | 0.001 | 8 (46.70) | 0.001 | 4 (25.00) | 0.001 |
| ANS impairment | ||||||||
| Parasympathetic dysfunction | 10 (24.00) | 0.057 | 3 (40.00) | 0.097 | 4 (22.20) | 0.131 | 1 (6.20) | 0.282 |
| Combined dysfunction | 30 (73.20) | 0.001 | 7 (100.00) | 0.001 | 15 (82.40) | 0.001 | 10 (60.00) | 0.001 |
| Autonomic neuropathy | 32 (78.00) | 0.018 | 6 (83.30) | 0.315 | 15 (82.40) | 0.069 | 11 (66.70) | 0.552 |
CART, cardioreflex test; CADG, COVID-19 group with associated diseases; CADG-DM, COVID-19 group with diabetes mellitus; CADG-HTA, COVID-19 group with hypertension; CADG-Syn, COVID-19 group with syncope.
Results are presented as counts (percent).
Bivariate analysis of severe and mild group with respect to controls is done by chi-squared test.